SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.04+2.6%Nov 21 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bull-like who wrote (6100)10/18/1998 10:32:00 PM
From: BigKNY3  Read Replies (1) of 9523
 
The European Agency for the Evaluation of Medicinal Products has posted their 42 page European Public Assessment Report on Viagra. Click on "Viagra" to open.
eudra.org

Here are some highlights from the Viagra Abstract:

-The approved indication is the treatment of erectile dysfunction.

-In clinical studies, the efficacy of Viagra was well established.

-The majority of the reported adverse events were mild or moderate in severity.

-No differences between sildenafil and placebo-treated subjects were observed in the overall safety database for mortality, all cardiovascular serious adverse events and myocardial infarction rate (adjusted to 100 man years of treatment).

-On the basis of efficacy and safety data submitted, considered that there was a favourable benefit to risk balance for Viagra and recommended that the Marketing Authorisation should be granted.

BigKNY3
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext